• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Embolism (1829); Ischemia (1942)
Event Date 06/29/2020
Event Type  Injury  
Event Description
It was reported that the patient experienced redness in the feet.Two 6x120x130 cm eluvia drug-eluting vascular stents were implanted in the superficial femoral artery (sfa).One non-bsc stent was implanted in the tibial artery.Three days post implantation of the stents, the patient's feet showed redness with signs of ischemia.Embolization was suspected.The patient was in stable condition.
 
Event Description
It was reported that the patient experienced redness in the feet.Two 6x120x130 cm eluvia drug-eluting vascular stents were implanted in the superficial femoral artery (sfa).One non-bsc stent was implanted in the tibial artery.Three days post implantation of the stents, the patient's feet showed redness with signs of ischemia.Embolization was suspected.The patient was in stable condition.It was further reported that the patient's feet looked normal prior to implanting the stents.The 100% stenosed target lesion was located in mild to moderately calcified superficial femoral artery (sfa).Vascular access was gained via ipsilateral downhill puncture.The lesion was predilated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10242140
MDR Text Key197850894
Report Number2134265-2020-09011
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number24653
Device Catalogue Number24653
Was Device Available for Evaluation? No
Date Manufacturer Received07/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-